Cargando…

The synergistic effect of EMT regulators and m6A modification on prognosis-related immunological signatures for ovarian cancer

Recently, there has been growing interest among researchers in exploring the effects of epithelial-mesenchymal transformation (EMT) or N6-Methyladenosine (m6A) modification regulators on tumor development. However, the synergistic efficiency of these regulators in relation to ovarian cancer developm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanna, Wang, Xun, Duan, Xiaogang, Du, Ting, Chen, Xiancheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491820/ https://www.ncbi.nlm.nih.gov/pubmed/37684273 http://dx.doi.org/10.1038/s41598-023-41554-y

Ejemplares similares

ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis
por: Zhang, Yanna, et al.
Publicado: (2022)

Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective
por: Zhang, Yanna, et al.
Publicado: (2021)

The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer
por: Zhu, Wenjing, et al.
Publicado: (2022)

An EMT‐related gene signature for the prognosis of human bladder cancer
por: Cao, Rui, et al.
Publicado: (2019)

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer
por: Cai, Luya, et al.
Publicado: (2020)

EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients
por: Lv, Yufei, et al.
Publicado: (2022)

A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer
por: Gao, Huabin, et al.
Publicado: (2021)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis
por: Su, Kuo-Min, et al.
Publicado: (2021)

METTL3-mediated m(6)A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung
por: Cheng, Cheng, et al.
Publicado: (2020)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma
por: Xiao, Zheng, et al.
Publicado: (2023)

Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
por: Song, Yang, et al.
Publicado: (2022)

Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1α Feedback Loop
por: Zhang, Tongshuo, et al.
Publicado: (2023)

Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021)

Clinicopathological and immunological characterization of RNA m(6)A methylation regulators in ovarian cancer
por: Wang, Qingying, et al.
Publicado: (2020)

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
por: Adzibolosu, Nicholas, et al.
Publicado: (2023)

An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers
por: Li, Qi-jia, et al.
Publicado: (2023)

Establishment and Analysis of an Individualized EMT-Related Gene Signature for the Prognosis of Breast Cancer in Female Patients
por: Xue, Wei, et al.
Publicado: (2022)

The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
por: Geng, Rui, et al.
Publicado: (2022)

m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer
por: Li, Ming, et al.
Publicado: (2022)

Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer
por: Peng, Caijiao, et al.
Publicado: (2022)

Retraction Notice to: METTL3-mediated m(6)A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung
por: Cheng, Cheng, et al.
Publicado: (2023)

Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration
por: Yue, Qingfang, et al.
Publicado: (2022)

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
por: Liu, Jinhui, et al.
Publicado: (2021)

Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer
por: Yu, Jing, et al.
Publicado: (2021)

A newly defined risk signature, consisting of three m(6)A RNA methylation regulators, predicts the prognosis of ovarian cancer
por: Fan, Lili, et al.
Publicado: (2020)

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms
por: Venugopal, Abhirami, et al.
Publicado: (2022)

The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
por: Meng, Zibo, et al.
Publicado: (2020)

Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types
por: Oh, Jaeik, et al.
Publicado: (2022)

The m(6)A-related gene signature for predicting the prognosis of breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2015)

Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma
por: XU, WENHAO, et al.
Publicado: (2023)

Novel gene signatures for prognosis prediction in ovarian cancer
por: Bao, Mingyang, et al.
Publicado: (2020)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Molecular signature of immunological mechanism behind impaired endometrial receptivity in polycystic ovarian syndrome
por: Amjadi, Fatemehsadat, et al.
Publicado: (2022)

Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas
por: Cai, Zhiqiang, et al.
Publicado: (2021)

The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer
por: Takai, Masaaki, et al.
Publicado: (2014)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5vn20mtotahq5et07665enao4